Hill Gaston
About
In The Last Decade
Hill Gaston
18 papers receiving 691 citations
Peers
Comparison fields: 5 of 90
- Immunology 346
- Rheumatology 178
- Cardiology and Cardiovascular Medicine 156
- Molecular Biology 149
- Epidemiology 86
Countries citing papers authored by Hill Gaston
This map shows the geographic impact of Hill Gaston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hill Gaston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hill Gaston more than expected).
Fields of papers citing papers by Hill Gaston
This network shows the impact of papers produced by Hill Gaston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hill Gaston. The network helps show where Hill Gaston may publish in the future.
Co-authorship network of co-authors of Hill Gaston
This figure shows the co-authorship network connecting the top 25 collaborators of Hill Gaston. A scholar is included among the top collaborators of Hill Gaston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hill Gaston. Hill Gaston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 67 | |
| 2 | 1 | |
| 3 | 4 | |
| 4 | Clinical experience with the European Ankylosing Spondylitis Infliximab Cohort (EASIC): long-term extension over 7 years with focus on clinical efficacy and safety. | 6 |
| 5 | 18 | |
| 6 | 198 | |
| 7 | 1 | |
| 8 | 0 | |
| 9 | The European ankylosing spondylitis infliximab cohort (EASIC): a European multicentre study of long term outcomes in patients with ankylosing spondylitis treated with infliximab. | 48 |
| 10 | 11 | |
| 11 | 13 | |
| 12 | 41 | |
| 13 | 19 | |
| 14 | 147 | |
| 15 | 1 | |
| 16 | 3 | |
| 17 | Cardiac rehabilitation as secondary prevention | 114 |
| 18 | 17 | |
| 19 | T-lymphocyte responses to Pneumocystis carinii in healthy and HIV-positive individuals. | 11 |
| 20 | Managing the red eye. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.